Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Biliary Tract Diseases

Free Subscription Articles published in Eur J Gastroenterol Hepatol Retrieve available abstracts of 38 articles: HTML format

Single Articles

March 2026
1. MEMON GM
   Endoscopic retrograde cholangiopancreatography discharge tool combined with rapid trypsinogen-2 test to predict same-day discharge: a prospective cohort study.
   Eur J Gastroenterol Hepatol. 2026;38:391.
   PubMed    
   
   
   
2. PARAKKAD AN
   Assessing ChatGPT's role in patient education on cholangiocarcinoma: promise, pitfalls, and a call for validation.
   Eur J Gastroenterol Hepatol. 2026;38:386-387.
   PubMed    
   
   
   
3. SILVEIRA IB, Moraes BF, Rezende RAA, Cancado GGL, et al
   Reconciling the role of ileal bile acid transporter inhibitors as symptom-directed therapy in primary biliary cholangitis: a focused meta-analysis.
   Eur J Gastroenterol Hepatol. 2026;38:384-385.
   PubMed    
   
   
   February 2026
4. SAH SS, Kumbhalwar A
   Comment on 'endoscopic retrograde cholangiopancreatography discharge tool combined with rapid trypsinogen-2 test to predict same-day discharge: a prospective cohort study'.
   Eur J Gastroenterol Hepatol. 2026;38:234.
   PubMed    
   
   
   January 2026
5. BIAN L, Luo L, Kang G, Liu Y, et al
   Safety evaluation of drug-eluting bead transarterial chemoembolization in combination with immune checkpoint inhibitors in the treatment of unresectable intrahepatic cholangiocarcinoma: risk factors for liver abscess.
   Eur J Gastroenterol Hepatol. 2026 Jan 15. doi: 10.1097/MEG.0000000000003141.
   PubMed     Abstract available
   
   
   December 2025
6. TANG L, Mo J, Ouyang J, Li W, et al
   A multilevel analysis of the genetic association between inflammatory bowel disease and primary sclerosing cholangitis.
   Eur J Gastroenterol Hepatol. 2025 Dec 9. doi: 10.1097/MEG.0000000000003116.
   PubMed     Abstract available
   
   
   September 2025
7. KOKER G
   Malignant bile duct obstruction and the microbiota: encouraging advances and unanswered questions.
   Eur J Gastroenterol Hepatol. 2025;37:1091.
   PubMed    
   
   
   July 2025
8. CUI Y, Li J, Huang Q, Hong J, et al
   Accuracy of the American Society for Gastrointestinal Endoscopy, European Society of Gastrointestinal Endoscopy, and Society of American Gastrointestinal and Endoscopic Surgeons criteria in predicting common bile duct microlithiasis.
   Eur J Gastroenterol Hepatol. 2025 Jul 18. doi: 10.1097/MEG.0000000000003037.
   PubMed     Abstract available
   
   
   June 2025
9. SPERNA WEILAND CJ, Engels MML, Scheffer RCH, Van Balkom B, et al
   Endoscopic retrograde cholangiopancreatography discharge tool combined with rapid trypsinogen-2 test to predict same-day discharge: a prospective cohort study.
   Eur J Gastroenterol Hepatol. 2025 Jun 18. doi: 10.1097/MEG.0000000000003014.
   PubMed     Abstract available
   
   
   May 2025
10. QIAN L, Wang L, Zou Z, Luan F, et al
    Distinct composition and metabolic potential of biliary microbiota in patients with malignant bile duct obstruction.
    Eur J Gastroenterol Hepatol. 2025;37:585-593.
    PubMed     Abstract available
    
    
    March 2025
11. HU Y, Liu M, Li S, Ji Y, et al
    Co-occurrence of autoimmune liver disease and gallstones: a clinically overlooked phenomenon.
    Eur J Gastroenterol Hepatol. 2025 Mar 26. doi: 10.1097/MEG.0000000000002978.
    PubMed     Abstract available
    
    
    
12. SAEED A, Yousuf S, Khan MA, Gangwani MK, et al
    Biliary stenting with and without endoscopic sphincterotomy in patients with malignant biliary obstruction: meta-analysis of randomized controlled trials.
    Eur J Gastroenterol Hepatol. 2025;37:257-262.
    PubMed     Abstract available
    
    
    February 2025
13. ZHAO Z, Wu H, Han J, Jiang K, et al
    Global trends and disparities in gallbladder and biliary tract cancers: insights from the global burden of disease study 2021.
    Eur J Gastroenterol Hepatol. 2025 Feb 14. doi: 10.1097/MEG.0000000000002947.
    PubMed     Abstract available
    
    
    December 2024
14. MOHAMED I, Naeem A, Hassan N, Jung D, et al
    Comparative efficacy and safety of SpyGlass percutaneous transhepatic cholangioscopy versus conventional cholangioscopy in challenging biliary access: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2024 Dec 17. doi: 10.1097/MEG.0000000000002909.
    PubMed     Abstract available
    
    
    
15. CHEN Q, Kong D, Liu X
    Secondary sclerosing cholangitis due to drug-induced liver injury: a retrospective cohort study.
    Eur J Gastroenterol Hepatol. 2024 Dec 2. doi: 10.1097/MEG.0000000000002902.
    PubMed     Abstract available
    
    
    
16. ZHANG R, Tan Y, Liu M, Wang L, et al
    Lymph node metastasis of intrahepatic cholangiocarcinoma: the present and prospect of detection and dissection.
    Eur J Gastroenterol Hepatol. 2024;36:1359-1369.
    PubMed     Abstract available
    
    
    November 2024
17. ZHANG S, Zhou T, Wu M, Xiong X, et al
    Sarcopenia is associated with new-onset acute biliary infection within 1 year in patients with hepatitis B virus-related decompensated cirrhosis.
    Eur J Gastroenterol Hepatol. 2024 Nov 8. doi: 10.1097/MEG.0000000000002875.
    PubMed     Abstract available
    
    
    September 2024
18. ZHAO J, Wang B, Zhao M, Pan X, et al
    Clinical and biochemical factors for bacteria in bile among patients with acute cholangitis.
    Eur J Gastroenterol Hepatol. 2024 Sep 11. doi: 10.1097/MEG.0000000000002849.
    PubMed     Abstract available
    
    
    July 2024
19. ZHOU X, Xu L, Zhang Q, Chen W, et al
    The impact of long-term (>/=5 years) cholecystectomy on gut microbiota changes and its influence on colorectal cancer risk: based on 16S rDNA sequencing analysis.
    Eur J Gastroenterol Hepatol. 2024 Jul 15. doi: 10.1097/MEG.0000000000002827.
    PubMed     Abstract available
    
    
    
20. DANIELSSON O, Vesterinen T, Arola J, Aberg F, et al
    Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease.
    Eur J Gastroenterol Hepatol. 2024;36:961-969.
    PubMed     Abstract available
    
    
    June 2024
21. POLPICHAI N, Saowapa S, Chan SY, Wattanachayakul P, et al
    Determining the association between systematic lupus erythematosus and the occurrence of primary biliary cirrhosis: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2024 Jun 19. doi: 10.1097/MEG.0000000000002791.
    PubMed     Abstract available
    
    
    
22. OZTURK NB, Jamil LH
    An assessment of risk factors for recurrence and survival for patients undergoing liver resection for intrahepatic cholangiocarcinoma.
    Eur J Gastroenterol Hepatol. 2024;36:766-774.
    PubMed     Abstract available
    
    
    May 2024
23. HUANG X, Chen W, Liu J, Liao Y, et al
    Clinicopathological features, prognostic factors, and prognostic survival prediction in patients with extrahepatic bile duct cancer liver metastasis.
    Eur J Gastroenterol Hepatol. 2024 May 31. doi: 10.1097/MEG.0000000000002799.
    PubMed     Abstract available
    
    
    
24. CANCADO GGL, Gomes NMF, Couto CA, Cancado ELR, et al
    A new and simple score to predict adequate and deep response to ursodeoxycholic acid in patients with primary biliary cholangitis: the ALP-A score.
    Eur J Gastroenterol Hepatol. 2024;36:628-635.
    PubMed     Abstract available
    
    
    April 2024
25. KIM NH, Kang JH, Kim HJ
    Association between nonalcoholic fatty liver disease and gallstone risk in nonobese and lean individuals.
    Eur J Gastroenterol Hepatol. 2024 Apr 17. doi: 10.1097/MEG.0000000000002779.
    PubMed     Abstract available
    
    
    
26. LEE DU, Harmacinski A, Kolachana S, Bahadur A, et al
    The role of donor sex on the post-liver transplant outcomes in patients with primary sclerosing cholangitis.
    Eur J Gastroenterol Hepatol. 2024;36:452-468.
    PubMed     Abstract available
    
    
    February 2024
27. LIANG X, Wang Z, Shu Q, Huang X, et al
    A bidirectional two-sample Mendelian randomization using the gut microbiota to reveal potential therapeutic targets for primary sclerosing cholangitis.
    Eur J Gastroenterol Hepatol. 2024;36:147-154.
    PubMed     Abstract available
    
    
    November 2023
28. ZHANG W, Chen Z, Sa B
    Construction and validation of the predictive model for gallbladder cancer liver metastasis patients: a SEER-based study.
    Eur J Gastroenterol Hepatol. 2023 Nov 24. doi: 10.1097/MEG.0000000000002678.
    PubMed     Abstract available
    
    
    October 2023
29. SUN N, Wang X, Wei J
    Gallstones, cholecystectomy and the risk of pancreatic cancer: an updated systematic review and meta-analysis of cohort studies.
    Eur J Gastroenterol Hepatol. 2023 Oct 6. doi: 10.1097/MEG.0000000000002652.
    PubMed     Abstract available
    
    
    September 2023
30. JENSEN AH, Ytting H, Winther-Sorensen M, Burisch J, et al
    Autoimmune liver diseases and diabetes.
    Eur J Gastroenterol Hepatol. 2023;35:938-947.
    PubMed     Abstract available
    
    
    August 2023
31. FORSTER K, Klein F, Simon N, Chhatwal P, et al
    Cultivation-based characterization of biliary microbiota in bile samples collected during routine endoscopic retrograde cholangiography: 10 years of experience at a tertiary center.
    Eur J Gastroenterol Hepatol. 2023 Aug 14. doi: 10.1097/MEG.0000000000002633.
    PubMed     Abstract available
    
    
    
32. RIGAMONTI C, De Benedittis C, Labanca S, Vanni E, et al
    Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years.
    Eur J Gastroenterol Hepatol. 2023;35:899-906.
    PubMed     Abstract available
    
    
    June 2023
33. HITAWALA AA, Almomani A, Onwuzo S, Boustany A, et al
    Prevalence of autoimmune, cholestatic and nonalcoholic fatty liver disease in celiac disease.
    Eur J Gastroenterol Hepatol. 2023 Jun 22. doi: 10.1097/MEG.0000000000002599.
    PubMed     Abstract available
    
    
    
34. RIGAMONTI C, De Benedittis C, Labanca S, Vanni E, et al
    Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years.
    Eur J Gastroenterol Hepatol. 2023 Jun 6. doi: 10.1097/MEG.0000000000002582.
    PubMed     Abstract available
    
    
    
35. TARAR ZI, Farooq U, Gandhi M, Ghous G, et al
    Effect of radiofrequency ablation in addition to biliary stent on overall survival and stent patency in malignant biliary obstruction: an updated systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2023;35:646-653.
    PubMed     Abstract available
    
    
    April 2023
36. DIAS B, Aguiar A, Morais CI, Nery FG, et al
    Correlation between individual autoantibodies and clinical features in primary biliary cholangitis: results of a retrospective longitudinal study.
    Eur J Gastroenterol Hepatol. 2023 Apr 17. doi: 10.1097/MEG.0000000000002565.
    PubMed     Abstract available
    
    
    
37. LI Z, Xu D, Yu H, Jiang H, et al
    Meta-analysis of the timing of laparoscopic cholecystectomy after endoscopic retrograde cholangiopancreatography in patients with cholecystolithiasis and choledocholithiasis.
    Eur J Gastroenterol Hepatol. 2023 Apr 11. doi: 10.1097/MEG.0000000000002553.
    PubMed     Abstract available
    
    
    February 2023
38. KARAAHMET F, Kekilli M
    Endoscopic retrograde cholangiopancreatography-oriented surgery for accomplished treatment of Mirizzi syndrome: a single-center experience.
    Eur J Gastroenterol Hepatol. 2023 Feb 27:e002534.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum